Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy

  1. Rivero-Juarez, A.
  2. Neukam, K.
  3. Labarga, P.
  4. Camacho, A.
  5. Macias, J.
  6. Barreiro, P.
  7. Torre-Cisneros, J.
  8. Pineda, J.A.
  9. Soriano, V.
  10. Rivero, A.
Revista:
Journal of Infection

ISSN: 1532-2742 0163-4453

Ano de publicación: 2014

Volume: 68

Número: 4

Páxinas: 372-377

Tipo: Artigo

DOI: 10.1016/J.JINF.2013.11.009 GOOGLE SCHOLAR

Obxectivos de Desenvolvemento Sustentable